Alvogen, Inc. Company Profile

09:40 EDT 4th July 2015 | BioPortfolio

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic selection of products, partners and markets, and the utilization of a consolidated global supply chain. The company has more than 130 pharmaceutical products in development and registration with several products expected to be launched in 2010. The product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of Oncology, Cardiology, Respiratory, Neurology and Gastroenterology.


News Articles [9 Associated News Articles listed on BioPortfolio]

Alvogen To Merge Korean Units, Plans Asian Expansion

U.S.-based pharmaceutical company Alvogen will merge its two South Korean subsidiaries - Kunwha Pharm and Dream Pharma - to create a new unit, Alvogen Korea, in June as part of its goal to become one ...

CVC Capital Partners leads consortium to acquire controlling stake in Alvogen

Consortium will provide funds to help Alvogen become a leading generics player worldwide

BRIEF-Cosmo Pharmaceuticals - Cosmo and Santarus file lawsuit against Alvogen

* Cosmo and Santarus file lawsuit against Alvogen for patent infringement of Uceris patents Source text for Eikon: Further company coverage: (Gdynia Newsroom)

LPC-CVC and Temasek to back Alvogen buy with existing $700m loan

LONDON, June 25 (Reuters) - European private equity fund CVC and Singaporean sovereign wealth fund Temasek are seeking to keep an existing $700 million leveraged loan financing for Alvogen in place to...

Exclusive: CVC and Temasek to buy $2billion generic drugs firm Alvogen

By Freya Berry LONDON (Reuters) - European private equity fund CVC and Singaporean sovereign wealth fund Temasek [TEM.UL] are to buy a controlling stake in the pharmaceutical firm Alvogen, its chairma...

Exclusive: CVC and Temasek to buy $2 billion generic drugs firm Alvogen

By Freya Berry LONDON (Reuters) - European private equity fund CVC and Singaporean sovereign wealth fund Temasek [TEM.UL] are to buy a controlling stake in the pharmaceutical firm Alvogen, its chairma...

Change of ownership for US generics firm Alvogen

A consortium of investors led by CVC Capital Partners and including Singapore-based investment company…

CVC Capital Partners leads investment consortium to acquire controlling stake in Alvogen

A consortium of investors led by CVC Capital Partners (“CVC”) and including Singapore-based investment company Temasek (“Temasek”) and Vatera Healthcare Partners (“Vater...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Alvogen Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen Pharma US, Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen, Inc. Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

More Information about "Alvogen, Inc." on BioPortfolio

We have published hundreds of Alvogen, Inc. news stories on BioPortfolio along with dozens of Alvogen, Inc. Clinical Trials and PubMed Articles about Alvogen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alvogen, Inc. Companies in our database. You can also find out about relevant Alvogen, Inc. Drugs and Medications on this site too.


Advertisement
 

Relevant Topics

Generics Drugs
Latest News Clinical Trials Research Drugs Reports Corporate
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Cancer
Latest News Clinical Trials Research Drugs Reports Corporate
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cardiology
Latest News Clinical Trials Research Drugs Reports Corporate
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record